Clover Past Earnings Performance

Past criteria checks 1/6

Clover's earnings have been declining at an average annual rate of -24.1%, while the Chemicals industry saw earnings growing at 17.7% annually. Revenues have been declining at an average rate of 3.6% per year. Clover's return on equity is 2.3%, and it has net margins of 2.4%.

Key information

-24.1%

Earnings growth rate

-24.3%

EPS growth rate

Chemicals Industry Growth	14.4%
Revenue growth rate	-3.6%
Return on equity	2.3%
Net Margin	2.4%
Last Earnings Update	31 Jul 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Clover makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

CHIA:CLV Revenue, expenses and earnings (AUD Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
31 Jul 24	62	2	11	2
30 Apr 24	62	2	11	3
31 Jan 24	63	2	11	3
31 Oct 23	71	4	11	3
31 Jul 23	80	6	12	3
30 Apr 23	83	7	11	2
31 Jan 23	85	9	10	2
31 Oct 22	78	8	9	2
31 Jul 22	71	7	9	2
30 Apr 22	66	6	9	2
31 Jan 22	61	6	9	2
31 Oct 21	61	6	8	2
31 Jul 21	61	6	8	2
30 Apr 21	70	8	8	2
31 Jan 21	80	10	8	3
31 Oct 20	84	11	9	2
31 Jul 20	88	12	9	2
30 Apr 20	84	11	9	2
31 Jan 20	80	10	9	2
31 Oct 19	78	10	9	2
31 Jul 19	77	10	9	2
30 Apr 19	71	9	8	2
31 Jan 19	66	9	8	1
31 Oct 18	65	8	7	1
31 Jul 18	63	8	7	2
30 Apr 18	61	7	6	1
31 Jan 18	59	6	5	1
31 Oct 17	54	5	5	1
31 Jul 17	48	4	5	1
30 Apr 17	45	3	5	1
31 Jan 17	43	2	5	1
31 Oct 16	43	2	5	1
31 Jul 16	43	2	5	1
30 Apr 16	38	1	5	1
31 Jan 16	34	0	5	2
31 Oct 15	32	0	5	2
31 Jul 15	30	0	5	2
30 Apr 15	29	0	4	2
31 Jan 15	28	0	4	2
31 Oct 14	28	1	4	2
31 Jul 14	27	1	5	2
30 Apr 14	33	3	5	2
31 Jan 14	39	5	6	2

Quality Earnings: CLV has high quality earnings.

Growing Profit Margin: CLV's current net profit margins (2.4%) are lower than last year (7.8%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CLV's earnings have declined by 24.1% per year over the past 5 years.

Accelerating Growth: CLV's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: CLV had negative earnings growth (-75.6%) over the past year, making it difficult to compare to the Chemicals industry average (4.4%).

Return on Equity

High ROE: CLV's Return on Equity (2.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/21 11:14
End of Day Share Price	2024/12/20 00:00
Earnings	2024/07/31
Annual Earnings	2024/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Clover Corporation Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Aaron Muller	Canaccord Genuity (Australia)
Alan Francis	CCZ Equities Pty Limited

Clover Past Earnings Performance

Past criteria checks 1/6

Key information

Recent past performance updates

Full year 2024 earnings released: EPS: AU$0.009 (vs AU$0.037 in FY 2023)

First half 2024 earnings released: AU$0.004 loss per share (vs AU$0.022 profit in 1H 2023)

Full year 2023 earnings released: EPS: AU$0.037 (vs AU$0.043 in FY 2022)

First half 2023 earnings released: EPS: AU$0.022 (vs AU$0.012 in 1H 2022)

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Full year 2021 earnings released: EPS AU$0.036 (vs AU$0.075 in FY 2020)

Recent updates

Dividend of AU$0.0075 announced

Full year 2024 earnings released: EPS: AU$0.009 (vs AU$0.037 in FY 2023)

New major risk - Revenue and earnings growth

Now 22% undervalued after recent price drop

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

Independent Non-Executive Chairman recently bought AU$100k worth of stock

Now 23% undervalued after recent price drop

First half 2024 earnings released: AU$0.004 loss per share (vs AU$0.022 profit in 1H 2023)

Clover Corporation Limited Declares Payment of Final Dividend for the Financial Year 2023

Insufficient new directors

Clover Corporation Limited, Annual General Meeting, Nov 23, 2023

New minor risk - Market cap size

Full year 2023 earnings released: EPS: AU$0.037 (vs AU$0.043 in FY 2022)

Clover Corporation Limited Declares Fully Franked Final Dividend for the Financial Year Ended 31 July 2023, Payable on 20 November 2023

First half 2023 earnings released: EPS: AU$0.022 (vs AU$0.012 in 1H 2022)

Clover Corporation Limited Payment of Final Dividend for the Financial Year 2022

Clover Informs Study Results by the South Australian Health and Medical Research Institute

Clover Corporation Limited Declares Fully Franked Final Dividend for the Year Ended 31 July 2022, Payable on 22 November 2022

Upcoming dividend of AU$0.01 per share

Clover Corporation Limited, Annual General Meeting, Nov 24, 2022

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

First half 2022 earnings: EPS in line with expectations, revenues disappoint

Now 23% undervalued after recent price drop

Full year 2021 earnings released: EPS AU$0.036 (vs AU$0.075 in FY 2020)

Investor sentiment improved over the past week

CFO & Company Secretary has left the company

Investor sentiment deteriorated over the past week

Clover Corporation Ltd Announces Payment of Interim Dividend for the Half Year Ended January 31, 2021

Investor sentiment improved over the past week

First half 2021 earnings released: EPS AU$0.015 (vs AU$0.028 in 1H 2020)

Clover Corporation Limited Provides Revenue Guidance for the Fiscal Year 2021

Clover Corporation Limited Declares Dividend for the First Half of 2021, Payable on April 29, 2021

New 90-day low: AU$1.45

New 90-day low: AU$1.47

New 90-day low: AU$1.62

CEO, MD & Director recently sold AU$404k worth of stock

Independent Chairman recently bought AU$99k worth of stock

Clover Corporation Limited Announces Board Changes

New 90-day low: AU$2.00

New 90-day low: AU$2.10

Full year earnings released

New 90-day high - AU$2.40

Revenue & Expenses Breakdown

Earnings and Revenue History

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Return on Equity

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data Sources

Analysis Model and Snowflake

Industry and Sector Metrics

Analyst Sources